本页面由Tiger Trade Technology Pte. Ltd.提供服务

Cullinan Therapeutics

21.68
+0.30001.40%
盘前21.60-0.0800-0.37%08:21 EDT
成交量:75.82万
成交额:1,641.49万
市值:13.95亿
市盈率:-6.25
高:22.11
开:21.72
低:21.40
收:21.38
52周最高:22.54
52周最低:5.68
股本:6,435.47万
流通股本:4,808.28万
量比:1.03
换手率:1.58%
股息:- -
股息率:- -
每股收益(TTM):-3.4680
每股收益(LYR):-3.7236
净资产收益率:-50.30%
总资产收益率:-31.36%
市净率:4.34
市盈率(LYR):-5.82

数据加载中...

2026/08/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/13

重要事件披露

Form 8-K - Current report
2026/08/07

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/07/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/16

重要事件披露

Form 8-K - Current report
2026/06/10

重要事件披露

Form 8-K - Current report
2026/06/08

重要事件披露

Form 8-K - Current report
2026/05/18

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/07

重要事件披露

Form 8-K - Current report
2026/05/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/10

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/10

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/10

重要事件披露

Form 8-K - Current report
2026/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities